Terms: = Germ cell tumor AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
40 results:
1. Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma.
Bai X; Attrill GH; Gide TN; Ferguson PM; Nahar KJ; Shang P; Vergara IA; Palendira U; da Silva IP; Carlino MS; Menzies AM; Long GV; Scolyer RA; Wilmott JS; Quek C
Nat Commun; 2024 Apr; 15(1):3014. PubMed ID: 38589406
[TBL] [Abstract] [Full Text] [Related]
2. Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Rubatto M; Fava P; Stanganelli I; Ribero S; Pigozzo J; Di Giacomo AM; Ridolfi L; Tronconi MC; Trojaniello C; Bersanelli M; Garutti M; Indini A; De Risi I; De Tursi M; Merelli B; Morgese F; Occelli M; Cappellini GCA; Poletto S; Fedele D; Brugnara S; Frisinghelli M; Formisano L; Conca R; Tucci M; Russillo M; Ceroni L; Queirolo P; Targato G; Strippoli S; Mandalà M; Guida M; Quaglino P
Eur J Cancer; 2023 Jul; 187():25-35. PubMed ID: 37099946
[TBL] [Abstract] [Full Text] [Related]
3. [Successful Postoperative Recurrence treatment of Malignant Melanoma of the Esophagus by Anti-PD-1 and Anti-CTLA-4 Combined Therapy-A Case Report].
Minagawa Y; Tanaka Y; Funatsuya T; Takahashi M
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1160-1162. PubMed ID: 36281619
[TBL] [Abstract] [Full Text] [Related]
4. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells.
Zhai K; Huang Z; Huang Q; Tao W; Fang X; Zhang A; Li X; Stark GR; Hamilton TA; Bao S
Nat Cancer; 2021 Nov; 2(11):1136-1151. PubMed ID: 35122055
[TBL] [Abstract] [Full Text] [Related]
6. Differentiation of tumorigenic C6 Glioma cells Induced by Enhanced IL-6 Signaling.
Chu IR; Pan RL; Yang CS
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33227992
[No Abstract] [Full Text] [Related]
7. [Metachronous Development of Mantle cell Lymphoma during Active Surveillance in a Patient with Stage I Testicular Cancer].
Sano K; Kimura T; Kawai K; Ikeda A; Ishitsuka R; Kandori S; Waku N; Hoshi A; Kojima T; Joraku A; Hashimoto R; Nishiyama H
Hinyokika Kiyo; 2018 Dec; 64(12):509-513. PubMed ID: 30831668
[TBL] [Abstract] [Full Text] [Related]
8. Serum angiogenesis profile in gestational trophoblastic neoplasm using multiplex immunoassay.
Banach P; Dereziński P; Matysiak J; Horała A; Swiatly A; Jasiński P; Kokot ZJ; Nowak-Markwitz E
Life Sci; 2018 Oct; 211():25-30. PubMed ID: 30195618
[TBL] [Abstract] [Full Text] [Related]
9. Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.
El Amrani M; Szanto CL; Hack CE; Huitema ADR; Nierkens S; van Maarseveen EM
Anal Bioanal Chem; 2018 Sep; 410(23):5849-5858. PubMed ID: 29938370
[TBL] [Abstract] [Full Text] [Related]
10. Inflammatory response and treatment tolerance of long-term infusion of the anti-GD
Ceylan K; Jahns LJ; Lode BN; Ehlert K; Kietz S; Troschke-Meurer S; Siebert N; Lode HN
Pediatr Blood Cancer; 2018 Jun; 65(6):e26967. PubMed ID: 29350486
[TBL] [Abstract] [Full Text] [Related]
11. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
Zhou J; Zhang C; Pan J; Chen L; Qi ST
Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
[TBL] [Abstract] [Full Text] [Related]
12. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
Chakrabarti M; Ray SK
Brain Res; 2015 Dec; 1629():85-93. PubMed ID: 26471408
[TBL] [Abstract] [Full Text] [Related]
14. Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.
Ara T; Nakata R; Sheard MA; Shimada H; Buettner R; Groshen SG; Ji L; Yu H; Jove R; Seeger RC; DeClerck YA
Cancer Res; 2013 Jul; 73(13):3852-64. PubMed ID: 23633489
[TBL] [Abstract] [Full Text] [Related]
15. Manganese induces oxidative stress, redox state unbalance and disrupts membrane bound ATPases on murine neuroblastoma cells in vitro: protective role of silymarin.
Chtourou Y; Trabelsi K; Fetoui H; Mkannez G; Kallel H; Zeghal N
Neurochem Res; 2011 Aug; 36(8):1546-57. PubMed ID: 21533646
[TBL] [Abstract] [Full Text] [Related]
16. Serum TNF-α, B2M and sil-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma.
Hofmann MA; Kiecker F; Küchler I; Kors C; Trefzer U
J Cancer Res Clin Oncol; 2011 Mar; 137(3):455-62. PubMed ID: 20454974
[TBL] [Abstract] [Full Text] [Related]
17. Pretreatment levels of sTNF-R1 and sil-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M
J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324
[TBL] [Abstract] [Full Text] [Related]
18. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Pastorino F; Brignole C; Di Paolo D; Nico B; Pezzolo A; Marimpietri D; Pagnan G; Piccardi F; Cilli M; Longhi R; Ribatti D; Corti A; Allen TM; Ponzoni M
Cancer Res; 2006 Oct; 66(20):10073-82. PubMed ID: 17047071
[TBL] [Abstract] [Full Text] [Related]
19. Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.
Bartlett JB; Michael A; Clarke IA; Dredge K; Nicholson S; Kristeleit H; Polychronis A; Pandha H; Muller GW; Stirling DI; Zeldis J; Dalgleish AG
Br J Cancer; 2004 Mar; 90(5):955-61. PubMed ID: 14997189
[TBL] [Abstract] [Full Text] [Related]
20. Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.
Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Bogenmann E; Ponzoni M; Montaldo PG
Cancer Lett; 2003 Jul; 197(1-2):151-5. PubMed ID: 12880975
[TBL] [Abstract] [Full Text] [Related]
[Next]
